- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05092178
Calorie Restricted Diet and Exercise
Effect of Calorie-restricted Diet and Exercise Intervention vs Exercise on the Knee Function of Metabolic Syndrome Patients With Degenerate Meniscus Lesions, a Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The CR diet and exercise group received a balanced diet with an energy consists carbohydrates 45-65%; fat 20-35%; and protein 10- 35% and a deficit of 600 kcal/day from their daily energy requirement. Total daily energy intake of 1200-2000 kcal/day were based on baseline weight, and for safety, no woman was provided with less than 1100 kcals/d and no man less than 1300 kcals/d. The energy of the intake calorie restricted diet per day was calculated based on the detailed composition of meals, such as rice, vegetables, eggs, pork, and beef, using the Chinese food composition tables. Our diets were cooked with traditional Chinese cooking methods such as boiling, stir-frying, and stewing. During the intervention, other lipid-lowering drugs were not allowed to intake supplement as it alters the outcome. Participants receive education or counseling by a dietitian for modulations of their caloric intake weekly.
The exercise intervention included aerobic exercises and resistance exercise, flexibility exercises about 150 minutes for ≥2 d/week for 6 months. The aerobic exercises included walking on a treadmill, stationary cycling for at least 30 minutes for≥2 d/week. Resistance exercises included nine upper-extremity and lower-extremity exercise with weighting lift machines for ≥2 d/week, while, flexibility exercise including the major muscle-tendon groups (a total of 60 s per exercise) for ≥2 d/week. Participants performed 1 or 2 sets with 8-12 repetitions of each exercise. The exercise sessions were monitored by telephone video. Patients who complete at least 80% of diet restriction and exercise were included in analysis. Calorie restricted diet and exercise group contain both the above intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Liaoning
-
Jinzhou, Liaoning, China, 121000
- First Affiliated Hospital of Jinzhou Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• Must be age between 35 and 70 years old;
- Clinical diagnosis of metabolic syndrome;
Exclusion Criteria:
• Must be able to have no acute knee injury such as car crash or acute sports injury;
- Must be able to have no knee surgeries history;
- Must be able to have no rheumatoid arthritis or serious knee osteoarthritis with deformity;
- Must be able to have no contraindications to MRI;
- Must be able to have no severe cardiopulmonary disease;
- Must be able to have no musculoskeletal or neuromuscular impairments ;
- Must be able to have good visual, hearing, or cognitive;
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Calorie restricted diet and exercise intervention
The CR diet and exercise group received a balanced diet with an energy consists carbohydrates 45-65%; fat 20-35%; and protein 10- 35% and a deficit of 600 kcal/day from their daily energy requirement. The exercise intervention included aerobic exercises and resistance exercise, flexibility exercises about 150 minutes for ≥2 d/week for 6 months. |
The CR diet and exercise group received a balanced diet with an energy consists carbohydrates 45-65%; fat 20-35%; and protein 10- 35% and a deficit of 600 kcal/day from their daily energy requirement.The exercise intervention consists of aerobic exercises and resistance exercise, flexibility exercises about 150 minutes for≥2 d•wk for six months.
The aerobic exercises included walking on a treadmill, stationary cycling for at least 30 minutes for≥2 d•wk, while, resistance exercises included nine upper-extremity and lower-extremity exercise with weighting lift machines for ≥2 d•wk, while, flexibility exercise including the major muscle-tendon groups (a total of 60 s per exercise) for ≥2 d•wk.
Participants performed 1 or 2 sets with 8-12 repetitions of each exercise.
The exercise sessions were monitored by telephone video.
|
Active Comparator: exercise group
In exercise alone group, participants then underwent their usual habitual dietary diet and the above exercise intervention during the program.
|
In exercise alone group, participants then underwent their usual habitual dietary diet and the above exercise intervention during the program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Knee injury and Osteoarthritis Outcome Score (KOOS) score change
Time Frame: Change from Baseline KOOS at 6 months
|
The Knee injury and Osteoarthritis Outcome Score (KOOS) holds five subscales including: Pain (9 items); other Symptoms (7 items); Activities of Daily Living (ADL, 17 items); Sport and Recreation function (Sport/Rec, 5 items); and knee-related Quality of Life (QoL, 4 items).
Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems)
|
Change from Baseline KOOS at 6 months
|
The International Knee Documentation Committee Subjective Knee Evaluation score change
Time Frame: Change from Baseline IKDC at 6 months
|
The International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC) score questionnaire contains 18 items (7 items for symptoms, 1 item for sport activity, 9 items for daily activities, and 1 item for current knee function.)
The total score is transformed to a value on a scale of 0 to 100, with 100 representing the highest knee function and 0 is the worst.
|
Change from Baseline IKDC at 6 months
|
The Knee injury and Osteoarthritis Outcome Score (KOOS) score change
Time Frame: Change from Baseline KOOS at 12 months
|
The Knee injury and Osteoarthritis Outcome Score (KOOS) holds five subscales including: Pain (9 items); other Symptoms (7 items); Activities of Daily Living (ADL, 17 items); Sport and Recreation function (Sport/Rec, 5 items); and knee-related Quality of Life (QoL, 4 items).
Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems)
|
Change from Baseline KOOS at 12 months
|
The International Knee Documentation Committee Subjective Knee Evaluation score change
Time Frame: Change from Baseline IKDC at 12 months
|
The International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC) score questionnaire contains 18 items (7 items for symptoms, 1 item for sport activity, 9 items for daily activities, and 1 item for current knee function.)
The total score is transformed to a value on a scale of 0 to 100, with 100 representing the highest knee function and 0 is the worst.
|
Change from Baseline IKDC at 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
subscales of KOOS pain score change
Time Frame: Change from Baseline pain at 6 months
|
Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life.The minimum is 0 points, the maximum is 4 points.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
|
Change from Baseline pain at 6 months
|
subscales of KOOS pain score change
Time Frame: Change from Baseline pain at 12 months
|
Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life.The minimum is 0 points, the maximum is 4 points.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
|
Change from Baseline pain at 12 months
|
subscales of KOOS symptoms score change
Time Frame: Change from Baseline symptoms at 6 months
|
Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life.
The minimum is 0 points, the maximum is 4 points.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
|
Change from Baseline symptoms at 6 months
|
subscales of KOOS symptoms score change
Time Frame: Change from Baseline symptoms at 12 months
|
Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life.
The minimum is 0 points, the maximum is 4 points.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
|
Change from Baseline symptoms at 12 months
|
KOOS activity of daily living change
Time Frame: Change from Baseline activity of daily living at 6 months
|
Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life.
The minimum is 0 points, the maximum is 4 points.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
|
Change from Baseline activity of daily living at 6 months
|
KOOS activity of daily living change
Time Frame: Change from Baseline activity of daily living at 12 months
|
Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life.
The minimum is 0 points, the maximum is 4 points.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
|
Change from Baseline activity of daily living at 12 months
|
sport and recreational function change
Time Frame: Change from Baseline sport and recreational function at 6 months
|
Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life.
The minimum is 0 points, the maximum is 4 points.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
|
Change from Baseline sport and recreational function at 6 months
|
sport and recreational function change
Time Frame: Change from Baseline sport and recreational function at 12 months
|
Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life.
The minimum is 0 points, the maximum is 4 points.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
|
Change from Baseline sport and recreational function at 12 months
|
knee related quality of life change
Time Frame: Change from Baseline knee related quality of life at 6 months
|
Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life.
The minimum is 0 points, the maximum is 4 points.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
|
Change from Baseline knee related quality of life at 6 months
|
knee related quality of life change
Time Frame: Change from Baseline knee related quality of life at 12 months
|
Secondary outcomes include five subscales of the KOOS covered pain, symptoms, activity of daily living, sport and recreational function, and knee related quality of life.
The minimum is 0 points, the maximum is 4 points.
After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
|
Change from Baseline knee related quality of life at 12 months
|
systolic blood pressure change
Time Frame: Change from Baseline systolic blood pressure at 6 months
|
systolic blood pressure /mmHg
|
Change from Baseline systolic blood pressure at 6 months
|
systolic blood pressure change
Time Frame: Change from Baseline systolic blood pressure at 12 months
|
systolic blood pressure /mmHg
|
Change from Baseline systolic blood pressure at 12 months
|
diastolic blood pressure change
Time Frame: Change from Baseline diastolic blood pressure at 6 months
|
diastolic blood pressure/mmHg
|
Change from Baseline diastolic blood pressure at 6 months
|
diastolic blood pressure change
Time Frame: Change from Baseline diastolic blood pressure at 12 months
|
diastolic blood pressure/mmHg
|
Change from Baseline diastolic blood pressure at 12 months
|
body mass index change
Time Frame: Change from Baseline body mass index at 6 months
|
body mass index /kg/㎡
|
Change from Baseline body mass index at 6 months
|
body mass index change
Time Frame: Change from Baseline body mass index at 12 months
|
body mass index /kg/㎡
|
Change from Baseline body mass index at 12 months
|
weight change
Time Frame: Change from Baseline weight at 6 months
|
Weight-kg
|
Change from Baseline weight at 6 months
|
weight change
Time Frame: Change from Baseline weight at 12 months
|
Weight-kg
|
Change from Baseline weight at 12 months
|
high-density lipoprotein cholesterol change
Time Frame: Change from Baseline high-density lipoprotein cholesterol at 6 months
|
high-density lipoprotein cholesterol (mmol/L)
|
Change from Baseline high-density lipoprotein cholesterol at 6 months
|
high-density lipoprotein cholesterol change
Time Frame: Change from Baseline high-density lipoprotein cholesterol at 12 months
|
high-density lipoprotein cholesterol (mmol/L)
|
Change from Baseline high-density lipoprotein cholesterol at 12 months
|
low-density lipoprotein cholesterol change
Time Frame: Change from Baseline low-density lipoprotein cholesterol at 6 months
|
low-density lipoprotein cholesterol (mmol/L)
|
Change from Baseline low-density lipoprotein cholesterol at 6 months
|
low-density lipoprotein cholesterol change
Time Frame: Change from Baseline low-density lipoprotein cholesterol at 12 months
|
low-density lipoprotein cholesterol (mmol/L)
|
Change from Baseline low-density lipoprotein cholesterol at 12 months
|
triglycerides change
Time Frame: Change from Baseline triglycerides at 6 months
|
triglycerides (mmol/l)
|
Change from Baseline triglycerides at 6 months
|
triglycerides change
Time Frame: Change from Baseline triglycerides at 12 months
|
triglycerides (mmol/l)
|
Change from Baseline triglycerides at 12 months
|
total cholesterol change
Time Frame: Change from Baseline total cholesterol at 6 months
|
total cholesterol (mmol/L)
|
Change from Baseline total cholesterol at 6 months
|
total cholesterol change
Time Frame: Change from Baseline total cholesterol at 12 months
|
total cholesterol (mmol/L)
|
Change from Baseline total cholesterol at 12 months
|
fast blood glucose change
Time Frame: Change from Baseline fast blood glucose at 6 months
|
fast blood glucose (mmol/L)
|
Change from Baseline fast blood glucose at 6 months
|
fast blood glucose change
Time Frame: Change from Baseline fast blood glucose at 12 months
|
fast blood glucose (mmol/L)
|
Change from Baseline fast blood glucose at 12 months
|
waist circumstance change
Time Frame: Change from Baseline waist circumstance at 6 months
|
waist circumstance (cm)
|
Change from Baseline waist circumstance at 6 months
|
waist circumstance change
Time Frame: Change from Baseline waist circumstance at 12 months
|
waist circumstance (cm)
|
Change from Baseline waist circumstance at 12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- exercise01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Universidad de los Andes, ChileCompleted
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
Taipei Medical University WanFang HospitalUnknownMetabolic Cardiovascular SyndromeTaiwan
-
Mayo ClinicCompleted
-
The Catholic University of KoreaCompletedMetabolic Syndrome X | Metabolic Cardiovascular Syndrome | Insulin Resistance Syndrome X | Dysmetabolic Syndrome XKorea, Republic of
-
University of HohenheimGerman Federal Ministry of Education and ResearchCompleted
-
Charite University, Berlin, GermanyRecruitingMetabolic Syndrome, Protection AgainstGermany
-
Wageningen University and ResearchPhilips Healthcare; TNO; Friesland Campina; Albert Heijn; Menzis; Smart with food; Vi... and other collaboratorsCompletedMetabolic Syndrome, Protection AgainstNetherlands
-
Cairo UniversityCompletedMetabolic Syndrome in WomenEgypt
-
Andalas UniversityHasanuddin University; Universitas Sumatera UtaraCompletedMetabolic Syndrome, Protection AgainstIndonesia
Clinical Trials on calorie restricted diet and exercise
-
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e...Federico II University; University of Modena and Reggio EmiliaUnknown
-
USDA Grand Forks Human Nutrition Research CenterNational Cancer Institute (NCI)CompletedObesity | Breast Cancer | OverweightUnited States
-
National University Hospital, SingaporeEnrolling by invitationObesity | Metabolic Syndrome | Weight Loss | Ketogenic DietingSingapore
-
Institute of Liver and Biliary Sciences, IndiaCompletedNon-Alcoholic Fatty Liver DiseaseIndia
-
University of CologneCompletedChronic Kidney DiseaseGermany
-
Meir Medical CenterUnknownPolycystic Ovary SyndromeIsrael
-
Nucleus of Education Interdisciplinary Research...Federal University of Juiz de ForaCompletedObesity | Metabolic Syndrome | Chronic Kidney DiseaseBrazil
-
Wake Forest University Health SciencesNational Heart, Lung, and Blood Institute (NHLBI)CompletedObesity | Weight Loss | CHD - Coronary Heart DiseaseUnited States
-
Mondelēz International, Inc.KGK Science Inc.CompletedEffect of South Beach Diet (SBD™) Using SBD™ Products Compared to a Calorie-Restricted Diet in WomenOverweightUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Not yet recruitingObesity | Iron Deficiency Anemia